In 2018, Dr. Kuypers was named the Principal Investigator for the Netherlands in the MAPS Phase 2 Clinical Trials of MDMA-Assisted Therapy for PTSD in Europe. Her current research interests are MDMA and psychedelics, and their effects on (social) cognition, creativity, hormones, and underlying brain mechanisms. Dr. Kuyper is an Associate Professor at the Faculty of Psychology and Neuroscience at Maastricht University, The Netherlands.
Her aim is to understand the neurobiology underlying flexible cognition, empathy, and well-being. Dr. Kuypers and her team employ a psychopharmacological model to study the (sub)acute and longer term effects of psychedelics on these behaviours and their underlying biology. Along with her colleague Prof. Jan Ramaekers, in collaboration with the Beckley Foundation, Dr. Kuypers and the team at Maastricht have been investigating the optimal dose of microdosing LSD to improve mood, cognition and pain resilience, with minimal side effects and interferences to day to day life.
Dr. Kim Kuypers received her MSc in Psychology and Neuropsychology in 2002 and her Ph.D. in Psychology and Psychopharmacology in 2007, both from Maastricht University. For the following four years, she remained in Maastricht conducting postdoctoral research into the effects of MDMA on memory and driving performance. Additionally, in 2011, she was also a postdoctoral researcher at Belgium’s Ghent University where she studied the risk analysis of alcohol and drugs in traffic accidents.